Artículos relacionados
Área salud
Un biomarcador oncosupresor se asocia a mejor prognosis en el melanoma
Además de ofrecer potencial en el diagnóstico, su elevada expresión se asocia a mayor supervivencia y a menor resistencia a algunos fármacos oncológicos.
Área salud
[Translated article] Practical Considerations About Optimal Skin Incisions/Excisions in Dermatologic Surgery with Emphasis on Incisions Orientation and Primary Cutaneous Melanoma Surgery
diciembre 27, 2022
Área salud, Actas Dermo-Sifiliográficas, Elsevier España, Medicina, Vol. 113. Núm. 5. (Mayo 2022)
Dermatologic surgery has 2 main objectives: 1) to guarantee surgical radicality; and 2) to achieve optimal aesthetic and functional results. These 2 paradigms and their hierarchy must be considered when performing surgical procedures on the […]
Área salud
Real-World Evidence of Adjuvant Immunotherapy in Resected Stage III and IV Melanoma Patients: CADIM Trial Final Results. Experience From 2 Tertiary Referral Centers
mayo 16, 2025
Área salud, Actas Dermo-Sifiliográficas, Elsevier España, Medicina, Vol. 116. Núm. 3. (marzo 2025)
Introduction Clinical trials have validated the use of nivolumab and pembrolizumab as adjuvant therapies regarding relapse-free survival in patients with resected stage III and IV melanoma. Evidence in real-world patients is currently limited. Material and […]
